Life Science Leader Magazine

JUL 2013

The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute

Issue link: https://lifescienceleadermag.epubxp.com/i/140470

Contents of this Issue

Navigation

Page 3 of 51

18 FEATURE: A DEPARTMENTS J&J;/JANSSEN 6 8 10 Bill Hait, M.D., Ph.D., global head of Janssen R&D;, explains some of the company's approaches to drug discovery which have resulted in J&J; recently being ranked by Forbes as the most productive drug firm in the last 10 years. 13 14 16 32 34 July 2013 CONTENTS Welcome to Life Science Leader 38 40 44 24 28 42 46 SPECIALTY PHARMA STRATEGIES BIOSIMILARS IN EMERGING MARKETS EXECUTIVE COMPENSATION 48 Learn the status of biosimilar market growth in five countries. New changes for rewarding pharma and bio executives How Aptalis uses the principles of mindset, mission, and model to guide the company to success BRAND 49 50 Editor's Note Editorial Board/Ask The Board Capitol Perspectives Entitlement Reform Companies To Watch Outsourcing Insights Prefilled Syringes Bio Innovation Notes Innovation In Bioprocessing Biopharm Dev. & Manufacturing Generic Drugs Drought Biopharm Dev. & Manufacturing Perils Of Building A Biotech In KY Global Business Update Norwegian Biotech Pharma Management Shifting Recruitment Patterns Pharma Manufacturing Update On Serialization Contract Sourcing GDUFA Insights Industry Leader Reformulating Drugs Industry Leader Electronic Source Records Leadership Lessons Importance Of Succession Planning Follow LSL on: @RFWrightLSL linkedin.com/in/robertfwright pintrest.com/rfwrightlsl 4 LifeScienceLeader.com July 2013

Articles in this issue

Links on this page

Archives of this issue

view archives of Life Science Leader Magazine - JUL 2013